Sun Pharma Advanced Research falls on reporting net loss of Rs 61 crore in Q1
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
Sun Pharma Advanced Research Company is currently trading at Rs. 243.40, down by 17.60 points or 6.74% from its previous closing of Rs. 261.00 on the BSE.
The scrip opened at Rs. 251.80 and has touched a high and low of Rs. 256.55 and Rs. 239.40 respectively. So far 252632 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 271.95 on 26-Jul-2021 and a 52 week low of Rs. 141.00 on 31-Mar-2021.
Last one week high and low of the scrip stood at Rs. 271.95 and Rs. 239.40 respectively. The current market cap of the company is Rs. 6420.16 crore.
The promoters holding in the company stood at 68.46%, while Institutions and Non-Institutions held 2.63% and 28.91% respectively.
Sun Pharma Advanced Research (SPARC) has reported net loss at Rs 61.37 crore for the quarter ended June 30, 2021 as compared to net profit of Rs 56.69 crore for the same quarter in the previous year. Total income of the company decreased by 87.75% at Rs 22.79 crore for Q1FY22 as compared Rs 186.11 crore for the corresponding quarter previous year.
SPARC is an international pharmaceutical company engaged in research and development of drugs and delivery systems.
